A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia after successfully completing Phase 1a trials in healthy volunteers, reports Griffith University’s Institute for Glycomics. The sepsis drug candidate, co-invented by researchers led by Professor Mark von Itzstein AO at the Institute for Glycomics and […]
Griffith University’s Clinical Trials Unit is the first globally to recruit patients for a multi-national rheumatology trial, and will also screen the first patient in Australia for a Meningococcal vaccine trial.
The Institute for Glycomics has been delivering major translational outcomes from its research in recent months, which will be celebrated during Glycomics Week. Glycomics Week highlights the Institute’s growing significant research successes. The Institute recently announced partnerships with Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc., for a new Strep A vaccine that has the enormous potential to help millions, […]
Griffith University’s Institute for Glycomics will open its doors to the public to showcase its malaria vaccine project.